Cargando…
Blunt dopamine transmission due to decreased GDNF in the PFC evokes cognitive impairment in Parkinson’s disease
Studies have found that the absence of glial cell line-derived neurotrophic factor may be the primary risk factor for Parkinson’s disease. However, there have not been any studies conducted on the potential relationship between glial cell line-derived neurotrophic factor and cognitive performance in...
Autores principales: | Tang, Chuan-Xi, Chen, Jing, Shao, Kai-Quan, Liu, Ye-Hao, Zhou, Xiao-Yu, Ma, Cheng-Cheng, Liu, Meng-Ting, Shi, Ming-Yu, Kambey, Piniel Alphayo, Wang, Wei, Ayanlaja, Abiola Abdulrahman, Liu, Yi-Fang, Xu, Wei, Chen, Gang, Wu, Jiao, Li, Xue, Gao, Dian-Shuai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827775/ https://www.ncbi.nlm.nih.gov/pubmed/36255000 http://dx.doi.org/10.4103/1673-5374.355816 |
Ejemplares similares
-
Failure of Glial Cell-Line Derived Neurotrophic Factor (GDNF) in Clinical Trials Orchestrated By Reduced NR4A2 (NURR1) Transcription Factor in Parkinson’s Disease. A Systematic Review
por: Kambey, Piniel Alphayo, et al.
Publicado: (2021) -
Glutathione S-Transferases S1, Z1 and A1 Serve as Prognostic Factors in Glioblastoma and Promote Drug Resistance through Antioxidant Pathways
por: Cheng, Bo, et al.
Publicado: (2022) -
Correction: Cheng et al. Glutathione S-Transferases S1, Z1 and A1 Serve as Prognostic Factors in Glioblastoma and Promote Drug Resistance through Antioxidant Pathways. Cells 2022, 11, 3232
por: Cheng, Bo, et al.
Publicado: (2023) -
Testosterone upregulates glial cell line-derived neurotrophic factor (GDNF) and promotes neuroinflammation to enhance glioma cell survival and proliferation
por: Kanwore, Kouminin, et al.
Publicado: (2023) -
Extracellular and Intracellular Factors in Brain Cancer
por: Kanwore, Kouminin, et al.
Publicado: (2021)